Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-09-29FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from Mannkind Corporation.
-
FDA approval · 2017-09-29FDA Approved: FIASP — Original Application (Novo Nordisk)
FDA approves the original application for FIASP (insulin aspart injection) by Novo Nordisk.
-
FDA approval · 2017-09-28FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Soliqua 100/33, the fixed-ratio combination of insulin glargine and lixisenatide, submitted …
-
EMA approval · 2017-09-28EMA Authorised: NovoNorm (repaglinide) — Novo Nordisk A/S
The EMA authorised NovoNorm (repaglinide) for type 2 diabetes, marking its approval in the European Union.
-
FDA approval · 2017-08-29FDA Approved: SOLIQUA 100/33 — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Soliqua 100/33, the fixed-ratio combination of insulin glargine and lixisenatide, submitted by S…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-08-25FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2017-08-16FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)
The FDA approved a supplemental application for GLUCOTROL XL (glipizide) submitted by Roerig.
-
FDA approval · 2017-08-14FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Metformin Hydrochloride from Granules Pharmaceuticals Inc., updating the regulatory status of th…
-
FDA approval · 2017-08-11FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2017-08-11FDA Approved: INVOKAMET XR — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET XR (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals.
-
FDA approval · 2017-08-10FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Tradjenta (linagliptin) filed by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2017-08-10FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) by Boehringer Ingelheim Pharmaceuticals…
-
FDA approval · 2017-08-10FDA Approved: JENTADUETO XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO XR (linagliptin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceut…
-
FDA approval · 2017-08-10FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUVIA (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2017-08-10FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC. The notice confi…
-
FDA approval · 2017-08-10FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride XR) from Merck Sharp & Dohme LLC.
-
FDA approval · 2017-08-10FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for GLYXAMBI (empagliflozin and linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc., repres…
-
FDA approval · 2017-08-01FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Trulicity (dulaglutide) submitted by Eli Lilly and Company. The action confirms approval of …
-
FDA approval · 2017-07-28FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Dapagliflozin and Metformin Hydrochloride (Prasco Laboratories), authorizing a new combinati…
-
FDA approval · 2017-07-25FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKANA (canagliflozin) from Janssen Pharmaceuticals, Inc. This approval updates the labeli…
-
FDA approval · 2017-07-25FDA Approved: INVOKAMET XR — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET XR, a fixed-dose combination of canagliflozin and metformin hydrochloride, by Jans…
-
FDA approval · 2017-06-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Eli Lilly’s insulin lispro, including a diluent component, updating the product’s labeling/admin…
-
FDA approval · 2017-05-12FDA Approved: GLIPIZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for GLIPIZIDE by Aurobindo Pharma Limited, authorizing a generic formulation of glipizide. The approva…
-
FDA approval · 2017-05-08FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA approved a supplemental application for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (insulin aspart protamine and insulin aspa…
-
FDA approval · 2017-04-25FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide submitted by Teva Pharmaceuticals USA, Inc. The approval updates the product’s label…